The Journal of Community and Supportive Oncology (JCSO) is a peer-reviewed journal featuring Original Research and Review articles, Case Reports, and How We Do It essays in clinical oncology and supportive care. It is distributed bimonthly as a digtial edition. The readership is comprised of practice-based medical oncologists and hematologists, supportive care specialists, mid-level providers, and pharmacists. JCSO keeps readers current in all aspects of cancer treatment, especially targeted therapies, immunotherapies, and novel drugs, as well as the latest findings on symptom management and patient care. This focus on the nexus between the oncology care team and patient well-being and outcomes throughout the disease continuum makes the journal a unique and vital clinical forum and resource in the supportive and practice settings.

Scroll down for 2017 Media Kit and Sales Contact details

A dynamic Features section rounds off the journal with regular articles under the headings of New Therapies (addressed by cancer type, eg, breast or multiple myeloma), Cancer & Comorbidity, Practice Management, Patient & Survivor Care, and The JCSO Podcast. In addition, the monthly Community Translations column and accompanying expert Commentary examine newly approved drugs and therapies and their translation into practice.

The JCSO is available bimonthly in a reader-friendly digital format, and as an app. Its website, www.jcso-online.com, features content organized by issue and further categorized by tumor type. Online readers also have access to podcasts for the bimonthly issue and The JSCO Interview, as well as daily oncology news updates written by a team of accomplished medical journalists, and physician-written perspectives and columns. In addition, the journal mails weekly e-newsletters of thematically curated published content as well as a a bimonthly electronic Table of Contents.

The JCSO print-web package delivers timely information in a readily accessible, interactive format. It’s the best way for oncologists to stay up to date and gain perspective on the latest advances.

Media Kit

Please click here to download the most current Integrated Media Kit.

Please click here to download the most current BPA Statement.

These documents are available for viewing in Adobe Acrobat Portable Document Format (PDF). PDF files require the Acrobat Reader software, which is available free of charge at the Adobe Web site.

Sales Contacts

Frank Iorio
Managing Director, Frontline Oncology
973-206-8990 (office)    917-913-8427 (cell)
fiorio@frontlinemedcom.com

Joshua Norton
Associate Director, e-Business Development
201-400-7644
jnorton@frontlinemedcom.com

 

JCSO Advertising & Promotions Policy

These guidelines govern various aspects of Advertising on JCSO and other Sites of Frontline Medical Communications. These Sites are directed to healthcare professionals. In this document,  the terms "Advertising" and "Advertisements" include third party banners, badges, contextual Advertising, Sponsored Content, and Promotions. The guidelines in this policy govern issues like acceptance of Advertisements and Promotions by Frontline Medical Communications and its affiliated Sites, how Advertisements and Promotions are displayed on Frontline Medical Communications, and the removal of Advertisements and Promotions from Frontline Medical Communications. Frontline Medical Communications has sole and absolute discretion with respect to interpretation and enforcement of this policy and all other issues associated with Advertising on the Frontline Medical Communications. Frontline Medical Communications may change this policy at any time by posting a revised policy to the applicable Frontline Medical Communications Sites.

  1. Frontline Medical Communications has sole discretion for determining the types of Advertising that will be accepted and displayed on Frontline Medical Communications, and under no circumstances will Frontline Medical Communications’ acceptance of any Advertisement be considered an endorsement of the product(s) and/or service(s) advertised or for the company that manufactures, distributes, or promotes the products or services.
  2. Frontline Medical Communications will not accept Advertising that, in Frontline Medical Communications’ opinion, is not factually accurate and in good taste.
  3. There are certain categories of advertisements that Frontline Medical Communications will not permit on the Frontline Medical Communications at any time. These categories include but are not limited to the following:
    • illegal or objectionable products
    • fraudulent, deceptive, illicit, misleading or offensive material
    • material that misrepresents, ridicules, discriminates (real or implied) or attacks an individual or group on the basis of age, national origin, race, religion, gender, sexual orientation, marital status, disability or any other status deemed inappropriate for Frontline Medical Communication.
    • alcohol
    • weapons, firearms, ammunition, or fireworks
    • gambling
    • pornography or related themes
    • tobacco use of any kind
    • the simulation of news or an emergency
    • material that directly advertises products to or is intended to attract children
    • media or messages for or that reference "M" rated video games or content
    • unreasonable, unlikely or extraordinary product or service claims
    • media messages or imagery that strobe or flash
    • media or messages that contain unsubstantiated "miracle" weight loss or other miracle claims of cure
    • advertising units that extend beyond the defined advertising space or interfere with the content or impact the readability of the content without user initiation
    • advertising units that do not retract to the defined advertising space upon user scroll off or contain a "close" or "X" for user to retract or close the ad unit/message after user initiation
    • advertising units that mimic computer functions or deceptively indicate a computer or other function that would be reasonable to the average user to assume as a reason to click the unit
  4. Advertisers must only offer products or services. The Advertising must also clearly identify the advertiser. Any Advertising that could be misconstrued as editorial content will be clearly labeled as Advertising.
  5. Frontline Medical Communications recognizes and maintains a distinct separation between advertising and sponsored content and editorial content. All Advertising, promotional, sponsored or marketing content on Frontline Medical Communications Sites will be clearly and unambiguously identified. Frontline Medical Communications will not allow any Advertising on at Frontline Medical Communications Sites that is not identified with the label of "Advertisement."
  6. A click on an Advertisement may only link the end user to the third-party advertiser's site or to relevant sponsored content area on a Frontline Medical Communications Site.
  7. While third party (sponsor produced) content must adhere to this Advertising Policy, labeling of Sponsored Content on the Frontline Medical Communications Sites is governed by Our Sponsor Policy, which describes how we label information from our Sponsors and the steps we take to help our end users understand the differences between Frontline Medical Communications content and Sponsored content.
  8. Advertising on the Frontline Medical Communications Sites may not link directly to a registration/email capture page. Any user registration or email capture pages resulting from an ad click must be, at minimum, two clicks away from the original Advertisement. Frontline Medical Communications will not run Advertising that requires registration and/or log-in in order to view a significant portion of the content of the Advertising or the related site. Frontline Medical Communications reserves the right to determine what level is 'significant'.
  9. Frontline Medical Communications reserves the right to reject, cancel, or remove at any time any Advertising from the Frontline Medical Communications Sites for any reason and will provide prompt notice to the advertiser upon rejection, cancellation, or removal of any Advertising, together with an explanation following the rejection, cancellation, or removal. Frontline Medical Communications also reserves the right to determine the appropriate placement of the Advertising on the Frontline Medical Communications Sites.
  10. It is the Advertiser's responsibility to comply with all applicable domestic and foreign laws, including applicable laws and regulations of regulatory bodies. This includes pharmaceutical advertising to physicians that must comply with FDA guidelines for Direct to Physician (DTP) and advertising. Frontline Medical Communications will not monitor compliance with applicable laws and regulations. However, Frontline Medical Communications reserves the right to review all Advertising for compliance with applicable laws and regulations and, if Frontline Medical Communications becomes aware of any breach or potential breach of any applicable law or regulation or of these guidelines, Frontline Medical Communications may remove the Advertising.
  11. No Advertising on the Frontline Medical Communications Sites shall include any pixels, tags, flash containers or any other type of information collection software code or shall place any beacons, cookies or other information collection devices on the browsers of Frontline Medical CommunicationsUsers unless expressly approved in writing by Frontline Medical Communications.
  12. No Advertising will be allowed on the Frontline Medical Communications Sites that could injure the good name or reputation of Frontline Medical Communications or any Frontline Medical Communications Site.

Last updated: February 24, 2017